Healthcare Industry News:  hematology analyzer 

Devices Neurology Monitoring Mergers & Acquisitions

 News Release - December 26, 2008

Nihon Kohden Announces Acquisition of Neurotronics Inc.

TOKYO, JAPAN - (HSMN NewsFeed) - Nihon Kohden Corporation (President: Fumio Suzuki) today announced the conclusion of a Stock Purchase Agreement for the acquisition of 100% of the shares of Neurotronics Incorporated (Headquarters: Gainesville, Florida, President: Jack Smith). Neurotronics will become a subsidiary of Nihon Kohden Corporation. The transfer day is December 31, 2008.

Although sleep apnea syndrome (SAS) has attracted attention in recent years, there are not many patients who are receiving continuous treatment for SAS. The number of potential patients is thought to be about two million in Japan, and it is forecast that PSG testing(1) that uses sleep brain wave analysis software to diagnose SAS will spread rapidly in the future.

Both Nihon Kohden and Neurotronics have worked for many years as valuable partners in sleep respiratory business. This partnership will strengthen development and the post-sales support of a product for the expanding sleep respiratory market by uniting the cranial nerve instrumentation technology of Nihon Kohden and the sleep brain wave analysis technology of Neurotronics with this purchase. Moreover, worldwide sales of the two company's products are expected to increase by using the global sales network of Nihon Kohden.

Known primarily for clinical medical instrumentation, Nihon Kohden also provides a high-quality product that utilizes medical, electronic technology in emergency medical care, home medical care, and promotion of better health. Nihon Kohden will continue development in the sleep respiratory business by building products that provide high additional value for global markets, and will contribute to the improvement of the quality of medical treatment while getting high support from employees, vendors, and shareholders as a leading company of the cranial nerve business in the future.

(1) PSG testing (Polysomnography all-night sleep polygraph testing): Testing of the patient to diagnose sleep respiratory problems. During an overnight stay, patient data is recorded during sleep for analysis and evaluation by a trained technician.

About Neurotronics, Inc.

Neurotronics Incorporated was established by Dr. Jack Smith to develop sleep analysis devices and software. Neurotronics develops, sells, and services a sleep data management suite of programs under the name Poly-suite, including the sleep brain wave analysis program Polysmith. Neurotronics has gained a reputation for quality products and customer support in the North American market.

About Nihon Kohden

Established in 1951, Nihon Kohden is Japan's leading manufacturer, developer and distributor of patient monitors, defibrillators, electrocardiographs, electroencephalographs, evoked potential and EMG systems, hematology analyzers, and other medical electronic equipment. The company has subsidiaries in the United States, Europe and Asia and distributors in most countries. For more information, visit the Company's web site at www.nihonkohden.com.


Source: Nihon Kohden

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.



FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.